These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7295488)

  • 1. The distribution of propranolol, pindolol and atenolol between human erythrocytes and plasma.
    Taylor EA; Turner P
    Br J Clin Pharmacol; 1981 Oct; 12(4):543-8. PubMed ID: 7295488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid concentrations of propranolol, pindolol and atenolol in man: evidence for central actions of beta-adrenoceptor antagonists.
    Taylor EA; Jefferson D; Carroll JD; Turner P
    Br J Clin Pharmacol; 1981 Oct; 12(4):549-59. PubMed ID: 6117308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol.
    Frewin DB; Penhall RK; Leonello PP; Clapp RJ
    N Z Med J; 1980 Nov; 92(672):389-90. PubMed ID: 6937768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein binding of atenolol and propranolol to human serum albumin and in human plasma [proceedings].
    Barber HE; Hawksworth GM; Kitteringham NR; Petersen J; Petrie JC; Swann JM
    Br J Clin Pharmacol; 1978 Nov; 6(5):446P-447P. PubMed ID: 728297
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.
    O'Connor PC; Finch MJ; Harron DW; Meredith PA; McDevitt DG; Shanks RG
    Br J Clin Pharmacol; 1985 Dec; 20(6):659-67. PubMed ID: 2868744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atenolol, pindolol and propranolol in essential hypertension: response rate and tolerance].
    Greminger P; Vetter H; Boerlin HJ; Baumgart P; Havelka J; Walger P; Lüscher T; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1982 Dec; 112(50):1831-5. PubMed ID: 7156966
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.
    Hallengren B; Nilsson OR; Karlberg BE; Melander A; Tegler L; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1982; 21(5):379-84. PubMed ID: 7075643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasts between pindolol and propranolol concentration-response relationships.
    Carruthers SG; Pacha WL; Aellig WH
    Br J Clin Pharmacol; 1985 Oct; 20(4):417-20. PubMed ID: 4074610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences of chronopharmacokinetic profiles between propranolol and atenolol in hypertensive subjects.
    Shiga T; Fujimura A; Tateishi T; Ohashi K; Ebihara A
    J Clin Pharmacol; 1993 Aug; 33(8):756-61. PubMed ID: 8408738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol.
    De Crée J; Cobo C; Geukens H; Verhaegen H
    Angiology; 1990 Feb; 41(2):95-105. PubMed ID: 1968323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of propranolol and atenolol in patients after partial gastric resection: a comparative study.
    Wójcicki J; Wojciechowski G; Wójcicki M; Kostyrka R; Sterna R; Gawronska-Szklarz B; Pawlik A; Drozdzik M; Kozlowski K
    Eur J Clin Pharmacol; 2000 Apr; 56(1):75-9. PubMed ID: 10853882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and evaluation of propranolol molecularly imprinted solid-phase microextraction fiber for trace analysis of beta-blockers in urine and plasma samples.
    Hu X; Pan J; Hu Y; Li G
    J Chromatogr A; 2009 Jan; 1216(2):190-7. PubMed ID: 19084232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of cimetidine with metoprolol, propranolol, or atenolol.
    Kirch W; Köhler H; Spahn H; Mutschler E
    Lancet; 1981 Sep; 2(8245):531-2. PubMed ID: 6115283
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative pharmacokinetics of propranolol and atenolol in primary hyperlipidemia.
    Telatyńska B; Wójcicki J; Droździk M; Gawrońska-Szklarz B; Sulzyc-Bielicka V; Sterna R
    Pol J Pharmacol; 2003; 55(1):81-9. PubMed ID: 12856830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular drugs in human mechanical nociception: digoxin, amlodipine, propranolol, pindolol and atenolol.
    Del Giaccio A; Eblen-Zajjur A
    Invest Clin; 2010 Mar; 51(1):77-86. PubMed ID: 20815158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise and the pharmacokinetics of propranolol, verapamil and atenolol.
    van Baak MA; Mooij JM; Schiffers PM
    Eur J Clin Pharmacol; 1992; 43(5):547-50. PubMed ID: 1483493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atenolol and three nonselective beta-blockers in hypertension.
    Waal-Manning HJ
    Clin Pharmacol Ther; 1979 Jan; 25(1):8-18. PubMed ID: 31259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective increase of plasma concentrations of the enantiomers of propranolol and atenolol during exercise.
    Stoschitzky K; Kahr S; Donnerer J; Schumacher M; Luha O; Maier R; Klein W; Lindner W
    Clin Pharmacol Ther; 1995 May; 57(5):543-51. PubMed ID: 7768077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.